22.01.24|Tomer Bronshtein“Despite their strong clinical data and established R&D programs, Israeli biotech companies are undervalued. Following two years of economic downturn, these companies now present attractive investment opportunities,” writes Dr. Tomer Bronshtein, VP for Innovation and Corporate Development at Bonus Biogroup
12.03.18|CTechMossad’s venture arm selects startups for its secretive portfolio. The city of Haifa is launching a digital health complex
12.03.18|Dror ReichUnlike conventional methods, Bonus Biogroup turns fat tissue collected from patients into bone grafts that can be transplanted with a minimally invasive procedure
21.12.17|CTechBlockchain loses magic hold on Tel Aviv investors. Activists out to change Israel's arm exports policies. The world’s first commercial-scale wave power plant will be built by Israel-based Yam Pro Energy in Ghana. Injectable bone grafts were demonstrated for the first time
21.12.17|Lilach BaumerThe Israel-based company's injectable bone grafts are made from fat cells taken from the patients to negate the risk of tissue rejection